Literature DB >> 24199795

Oxacillin-susceptible MRSA: could it become a successful MRSA type?

Spyros Pournaras1, Constantinos Stathopoulos, Athanassios Tsakris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24199795     DOI: 10.2217/fmb.13.118

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


× No keyword cloud information.
  5 in total

1.  Prevalence and Characterization of Oxacillin Susceptible mecA-Positive Clinical Isolates of Staphylococcus aureus Causing Bovine Mastitis in India.

Authors:  Hiral Mistry; Paresh Sharma; Sudipta Mahato; R Saravanan; P Anand Kumar; Vasundhra Bhandari
Journal:  PLoS One       Date:  2016-09-07       Impact factor: 3.240

2.  Dissemination Of t437-SCCmecIV And Coagulase-Negative t037-SCCmecIII Types Among Borderline Oxacillin-Resistant Staphylococcus aureus Isolated From Skin Infections And Diabetic Foot Ulcers.

Authors:  Maria Stańkowska; Katarzyna Garbacz; Lidia Piechowicz; Marek Bronk
Journal:  Infect Drug Resist       Date:  2019-10-10       Impact factor: 4.003

3.  Comparison of biofilm formation between major clonal lineages of methicillin resistant Staphylococcus aureus.

Authors:  Evelyn Vanhommerig; Pieter Moons; Daniel Pirici; Christine Lammens; Jean-Pierre Hernalsteens; Henri De Greve; Samir Kumar-Singh; Herman Goossens; Surbhi Malhotra-Kumar
Journal:  PLoS One       Date:  2014-08-08       Impact factor: 3.240

4.  Genetic Characterization of Staphylococcus aureus Isolated from Retail Meat in Riyadh, Saudi Arabia.

Authors:  Muhabat A Raji; Ghada Garaween; Ralf Ehricht; Stefan Monecke; Atef M Shibl; Abiola Senok
Journal:  Front Microbiol       Date:  2016-06-09       Impact factor: 5.640

5.  Epidemiology of Staphylococcus aureus in neonates on admission to a Chinese neonatal intensive care unit.

Authors:  Wenjing Geng; Yujie Qi; Wenting Li; Thomas H McConville; Alexandra Hill-Ricciuti; Emily C Grohs; Lisa Saiman; Anne-Catrin Uhlemann
Journal:  PLoS One       Date:  2020-02-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.